LitCovid-sample-Enju  

PMC:7205724 / 20533-21806 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T20998 0-3 CD denotes 6.1
T79456 5-14 VBG denotes Targeting
T24060 15-18 DT denotes the
T56819 19-20 NN denotes S
T25577 21-28 NN denotes protein
T96682 30-35 CD denotes 6.1.1
T17328 37-47 NN denotes Hypothesis
T61727 47-48 -COLON- denotes :
T32221 49-50 DT denotes A
T25878 51-54 NN denotes mAb
T8625 55-62 IN denotes against
T32030 63-66 DT denotes the
T55531 67-74 NN denotes binding
T9970 75-81 NN denotes domain
T76093 82-84 IN denotes of
T80345 85-88 DT denotes the
T93532 89-94 NN denotes virus
T16199 95-98 MD denotes can
T28417 99-106 VB denotes inhibit
T48409 107-116 NN denotes SARS-CoV2
T36310 117-126 NN denotes infection
T27915 127-135 RB denotes Recently
T56144 135-136 -COMMA- denotes ,
T55915 137-146 NN denotes hybridoma
T72012 147-159 NNS denotes supernatants
T47163 160-170 VBG denotes containing
T24138 171-179 NN denotes antibody
T98139 180-191 NNS denotes repertoires
T66535 192-196 IN denotes from
T86473 197-206 VBN denotes immunized
T66245 207-217 JJ denotes transgenic
T17100 218-222 NNS denotes mice
T85324 223-227 WDT denotes that
T55347 228-235 VBP denotes express
T14738 236-239 DT denotes the
T52540 240-245 JJ denotes human
T35586 246-260 NN denotes immunoglobulin
T72563 261-266 JJ denotes heavy
T65069 267-270 CC denotes and
T5967 271-276 JJ denotes light
T98095 277-283 NNS denotes chains
T78221 284-287 CC denotes and
T28318 288-291 NN denotes rat
T19776 292-298 NN denotes origin
T32531 299-313 NN denotes immunoglobulin
T16968 314-322 NN denotes constant
T56920 323-330 NNS denotes regions
T36716 331-335 VBD denotes were
T74827 336-340 VBN denotes used
T21382 341-343 TO denotes to
T11788 344-350 VB denotes detect
T40665 351-361 NNS denotes antibodies
T56747 362-366 WDT denotes that
T54239 367-370 MD denotes can
T71867 371-376 VB denotes cross
T35671 377-387 VB denotes neutralize
T77445 388-394 NN denotes SARS-S
T34654 395-398 CC denotes and
T83470 399-407 NN denotes SARS-2-S
T76245 408-409 -LRB- denotes [
T33581 409-411 CD denotes 26
T80577 411-412 -RRB- denotes ]
T78516 414-417 CD denotes One
T34464 418-426 JJ denotes chimeric
T13041 427-432 NN denotes 47D11
T83927 433-437 NN denotes H2L2
T57345 438-446 NN denotes antibody
T44833 447-456 VBD denotes displayed
T94688 457-461 PDT denotes such
T52983 462-463 DT denotes a
T30646 464-482 JJ denotes cross-neutralizing
T37245 483-491 NN denotes activity
T11300 491-492 -COMMA- denotes ,
T30814 493-502 VBD denotes decreased
T23282 503-511 NN denotes syncytia
T72581 512-521 NN denotes formation
T71888 522-529 VBN denotes induced
T44111 530-532 IN denotes by
T7869 533-539 NN denotes SARS-S
T80909 540-543 CC denotes and
T58127 544-551 NN denotes SARS2-S
T9479 551-552 -COMMA- denotes ,
T96346 553-556 CC denotes and
T43362 557-562 MD denotes could
T48435 563-570 VB denotes protect
T44775 571-577 NN denotes VeroE6
T25625 578-583 NNS denotes cells
T19104 584-591 IN denotes against
T51640 592-598 NN denotes SARS-S
T22676 599-602 CC denotes and
T37470 603-610 NN denotes SARS2-S
T64695 611-622 VBD denotes pseudotyped
T26978 623-628 NN denotes virus
T79137 629-630 -LRB- denotes [
T95558 630-632 CD denotes 26
T95168 632-633 -RRB- denotes ]
T45371 635-637 PRP denotes It
T75403 638-641 MD denotes may
T86603 642-645 VB denotes lie
T91829 646-648 IN denotes in
T48175 649-652 PRP-DOLLAR- denotes its
T69338 653-660 JJ denotes similar
T68140 661-671 NNS denotes affinities
T76951 672-675 IN denotes for
T38362 676-687 VBG denotes interacting
T39715 688-692 IN denotes with
T48378 693-696 DT denotes the
T63623 697-701 JJ denotes same
T2491 702-708 NN denotes domain
T57621 709-711 IN denotes of
T77993 712-715 DT denotes the
T52886 716-718 NN denotes S1
T27554 719-726 NN denotes subunit
T41139 726-727 -COMMA- denotes ,
T99819 728-732 FW denotes i.e.
T40027 732-733 -COMMA- denotes ,
T73637 734-737 NN denotes S1B
T71055 737-738 -COMMA- denotes ,
T88888 739-741 IN denotes of
T40209 742-746 DT denotes each
T2572 747-753 NN denotes SARS-S
T97128 754-757 CC denotes and
T91104 758-766 NN denotes SARS-2-S
T63608 769-774 CD denotes 6.1.2
T11815 776-784 NNP denotes Rational
T73902 784-785 -COLON- denotes :
T21134 786-789 DT denotes The
T30867 790-798 JJ denotes chimeric
T42126 799-804 NN denotes 47D11
T93924 805-809 NN denotes H2L2
T85248 810-815 MD denotes might
T92338 816-819 RB denotes not
T49873 820-822 VB denotes be
T69919 823-832 JJ denotes effective
T60557 833-835 IN denotes in
T77242 836-841 JJ denotes human
T86725 842-846 NN denotes lung
T18333 847-852 NNS denotes cells
T22947 853-855 IN denotes as
T22184 856-858 PRP denotes it
T1922 859-861 VBZ denotes is
T72123 862-864 FW denotes in
T38972 865-870 FW denotes vitro
T22398 871-876 NN denotes 47D11
T15962 877-884 VBD denotes carried
T83196 885-886 DT denotes a
T61532 887-893 JJR denotes higher
T47874 894-902 NN denotes affinity
T77580 903-906 IN denotes for
T95631 907-918 VBG denotes interacting
T94847 919-923 IN denotes with
T20163 924-927 DT denotes the
T18520 928-930 NN denotes S2
T89003 931-938 NN denotes subunit
T41606 939-941 IN denotes of
T4784 942-948 NN denotes SARS-S
T32288 949-953 IN denotes than
T68894 954-958 DT denotes that
T97000 959-961 IN denotes of
T32517 962-971 NN denotes SARS-2-S.
T24633 972-974 PRP denotes It
T45480 975-977 VBZ denotes is
T10954 978-987 JJ denotes important
T96386 988-992 IN denotes that
T80967 993-996 IN denotes for
T24571 997-1001 DT denotes both
T18211 1002-1008 NN denotes SARS-S
T39196 1009-1012 CC denotes and
T83081 1013-1021 NN denotes SARS-2-S
T70298 1021-1022 -COMMA- denotes ,
T91479 1023-1026 DT denotes the
T56884 1027-1034 NN denotes binding
T11559 1035-1037 IN denotes of
T2922 1038-1041 DT denotes the
T11592 1042-1047 NN denotes 47D11
T36887 1048-1056 NN denotes antibody
T46706 1057-1059 TO denotes to
T40788 1060-1063 DT denotes the
T37833 1064-1070 NN denotes target
T37378 1071-1072 VBZ denotes –
T15003 1073-1076 DT denotes the
T4372 1077-1080 NN denotes S1B
T31100 1081-1087 NN denotes domain
T82065 1088-1089 NN denotes –
T43926 1090-1094 VBZ denotes does
T69422 1095-1098 RB denotes not
T3419 1099-1104 VB denotes block
T21955 1105-1108 DT denotes the
T12942 1109-1116 NN denotes binding
T83444 1117-1119 IN denotes of
T49120 1120-1123 NN denotes S1B
T55070 1124-1127 CC denotes and
T98634 1128-1130 NN denotes S2
T48321 1131-1133 TO denotes to
T80580 1134-1138 NN denotes ACE2
T18877 1139-1147 NN denotes receptor
T18503 1148-1149 -LRB- denotes [
T33177 1149-1151 CD denotes 26
T92006 1151-1152 -RRB- denotes ]
T53652 1154-1156 IN denotes By
T58622 1157-1165 NN denotes contrast
T35381 1165-1166 -COMMA- denotes ,
T41843 1167-1179 VBG denotes neutralizing
T81589 1180-1190 NNS denotes antibodies
T68196 1191-1195 WDT denotes that
T30816 1196-1208 RB denotes specifically
T53446 1209-1215 NN denotes target
T89813 1216-1222 NN denotes SARS-S
T95236 1223-1228 MD denotes could
T7888 1229-1236 VB denotes compete
T34125 1237-1241 IN denotes with
T82101 1242-1245 NN denotes S1B
T1902 1246-1249 CC denotes and
T24277 1250-1252 NN denotes S2
T37015 1253-1256 IN denotes for
T86465 1257-1264 VBG denotes binding
T1893 1265-1267 TO denotes to
T91196 1268-1272 NN denotes ACE2
R10178 T33581 T76245 arg2Of 26,[
R10371 T37833 T46706 arg2Of target,to
R10518 T98095 T5967 arg1Of chains,light
R10738 T17100 T86473 arg2Of mice,immunized
R10947 T68894 T97000 arg1Of that,of
R12224 T80577 T76245 arg3Of ],[
R12801 T11788 T21382 arg1Of detect,to
R14961 T89813 T53446 arg1Of SARS-S,target
R15040 T95631 T94847 arg1Of interacting,with
R15396 T25878 T28417 arg1Of mAb,inhibit
R15467 T37378 T70298 arg1Of –,","
R16446 T47874 T45480 modOf affinity,is
R17122 T2491 T39715 arg2Of domain,with
R17475 T68140 T76951 arg1Of affinities,for
R17566 T56884 T37378 arg1Of binding,–
R20587 T25878 T16199 arg1Of mAb,can
R2062 T97128 T40209 arg1Of and,each
R21425 T95168 T79137 arg3Of ],[
R22045 T86603 T75403 arg2Of lie,may
R22781 T18333 T77242 arg1Of cells,human
R22914 T98139 T55347 arg1Of repertoires,express
R23617 T3419 T37378 arg2Of block,–
R23833 T9970 T8625 arg2Of domain,against
R23893 T26978 T64695 arg3Of virus,pseudotyped
R2391 T7888 T30816 arg1Of compete,specifically
R24043 T38362 T76951 arg2Of interacting,for
R24714 T40665 T71867 arg1Of antibodies,cross
R24972 T68140 T41139 arg1Of affinities,","
R25119 T28417 T16199 arg2Of inhibit,can
R25517 T89003 T94847 arg2Of subunit,with
R25704 T98139 T47163 arg2Of repertoires,containing
R26619 T82065 T15003 arg1Of –,the
R27208 T45371 T86603 arg1Of It,lie
R27252 T93924 T30867 arg1Of H2L2,chimeric
R27880 T10954 T45480 arg2Of important,is
R28532 T25577 T79456 arg2Of protein,Targeting
R29418 T35671 T71867 arg2Of neutralize,cross
R2953 T72581 T23282 arg1Of formation,syncytia
R29816 T2491 T63623 arg1Of domain,same
R30150 T12942 T83444 arg1Of binding,of
R30509 T27554 T52886 arg1Of subunit,S1
R30813 T93924 T69919 arg1Of H2L2,effective
R30853 T86603 T91829 arg1Of lie,in
R31979 T9970 T76093 arg1Of domain,of
R32317 T57345 T30814 arg1Of antibody,decreased
R32719 T17328 T96682 arg1Of Hypothesis,6.1.1
R33694 T48435 T43362 arg2Of protect,could
R33937 T56920 T78221 arg2Of regions,and
R3397 T47874 T83196 arg1Of affinity,a
R33983 T74827 T27915 arg1Of used,Recently
R34441 T17328 T61727 arg1Of Hypothesis,:
R34556 T89003 T41606 arg1Of subunit,of
R34720 T3419 T43926 arg2Of block,does
R34990 T99819 T40027 arg1Of i.e.,","
R35148 T12942 T21955 arg1Of binding,the
R3528 T98634 T55070 arg2Of S2,and
R35318 T2572 T97128 arg1Of SARS-S,and
R35747 T56884 T46706 arg1Of binding,to
R36055 T55070 T83444 arg2Of and,of
R3636 T91196 T1893 arg2Of ACE2,to
R36916 T37833 T40788 arg1Of target,the
R37042 T18877 T80580 arg1Of receptor,ACE2
R37082 T57345 T44833 arg1Of antibody,displayed
R37108 T22398 T15962 arg1Of 47D11,carried
R37253 T11300 T96346 arg1Of ",",and
R37476 T40665 T54239 arg1Of antibodies,can
R37706 T4784 T41606 arg2Of SARS-S,of
R3874 T2491 T57621 arg1Of domain,of
R39175 T82101 T1902 arg1Of S1B,and
R39394 T93924 T21134 arg1Of H2L2,The
R39715 T72581 T71888 arg2Of formation,induced
R3997 T89003 T18520 arg1Of subunit,S2
R40504 T89813 T7888 arg1Of SARS-S,compete
R41077 T92006 T18503 arg3Of ],[
R42165 T37245 T44833 arg2Of activity,displayed
R42535 T41843 T35381 arg1Of neutralizing,","
R42573 T22676 T64695 arg2Of and,pseudotyped
R43602 T47874 T15962 arg2Of affinity,carried
R44270 T97128 T88888 arg2Of and,of
R44320 T25625 T48435 arg2Of cells,protect
R45591 T37378 T96386 arg2Of –,that
R45757 T81589 T68196 arg1Of antibodies,that
R45826 T47874 T32288 arg1Of affinity,than
R47400 T82065 T43926 arg1Of –,does
R47571 T2491 T48378 arg1Of domain,the
R48015 T68140 T99819 arg1Of affinities,i.e.
R48027 T7888 T34125 arg1Of compete,with
R48343 T36887 T11592 arg1Of antibody,47D11
R48482 T96346 T9479 arg1Of and,","
R48595 T44833 T11300 arg1Of displayed,","
R49211 T1922 T22947 arg2Of is,as
R5031 T20998 T79456 arg1Of 6.1,Targeting
R5059 T24633 T10954 arg1Of It,important
R50898 T98095 T52540 arg1Of chains,human
R51485 T27554 T57621 arg2Of subunit,of
R51826 T82065 T3419 arg1Of –,block
R51991 T5967 T65069 arg2Of light,and
R52958 T40665 T11788 arg2Of antibodies,detect
R53417 T89003 T20163 arg1Of subunit,the
R53752 T80909 T71888 arg1Of and,induced
R53767 T86465 T1893 arg1Of binding,to
R54102 T93532 T80345 arg1Of virus,the
R54251 T68140 T69338 arg1Of affinities,similar
R54339 T25625 T44775 arg1Of cells,VeroE6
R54748 T98095 T72563 arg1Of chains,heavy
R5494 T56884 T91479 arg1Of binding,the
R55425 T57345 T78516 arg1Of antibody,One
R55511 T12942 T48321 arg1Of binding,to
R55576 T33177 T18503 arg2Of 26,[
R55812 T3419 T69422 arg1Of block,not
R56902 T69919 T49873 arg2Of effective,be
R57443 T9970 T55531 arg1Of domain,binding
R57766 T18211 T39196 arg1Of SARS-S,and
R57799 T45371 T75403 arg1Of It,may
R57926 T49873 T22947 arg1Of be,as
R58250 T17328 T16199 modOf Hypothesis,can
R58716 T37470 T22676 arg2Of SARS2-S,and
R58851 T37245 T52983 arg1Of activity,a
R59163 T1902 T34125 arg2Of and,with
R60499 T22184 T1922 arg1Of it,is
R60594 T83081 T39196 arg2Of SARS-2-S,and
R62361 T36887 T2922 arg1Of antibody,the
R62516 T26978 T79137 arg1Of virus,[
R63011 T17100 T66535 arg2Of mice,from
R63116 T78221 T14738 arg1Of and,the
R6420 T1902 T37015 arg1Of and,for
R6463 T49873 T60557 arg1Of be,in
R64854 T82065 T4372 arg1Of –,S1B
R65646 T72012 T36716 arg1Of supernatants,were
R66835 T74827 T56144 arg1Of used,","
R66912 T72581 T30814 arg2Of formation,decreased
R67139 T74827 T36716 arg2Of used,were
R67161 T22676 T19104 arg2Of and,against
R6725 T37245 T30646 arg1Of activity,cross-neutralizing
R67300 T86465 T37015 arg2Of binding,for
R6780 T7888 T95236 arg2Of compete,could
R67837 T72012 T74827 arg2Of supernatants,used
R67960 T51640 T22676 arg1Of SARS-S,and
R6804 T36310 T48409 arg1Of infection,SARS-CoV2
R68061 T1922 T38972 arg1Of is,vitro
R68664 T49873 T85248 arg2Of be,might
R6870 T11815 T63608 arg1Of Rational,6.1.2
R6871 T96386 T80967 arg1Of that,for
R68866 T41843 T53652 arg1Of neutralizing,By
R68969 T95631 T77580 arg2Of interacting,for
R68991 T95558 T79137 arg2Of 26,[
R69341 T11788 T74827 arg3Of detect,used
R69683 T47874 T61532 arg1Of affinity,higher
R6992 T36887 T11559 arg2Of antibody,of
R6996 T98095 T35586 arg1Of chains,immunoglobulin
R70086 T34654 T35671 arg2Of and,neutralize
R70730 T38972 T72123 arg1Of vitro,in
R73215 T57345 T43362 arg1Of antibody,could
R73472 T93924 T49873 arg1Of H2L2,be
R73905 T27554 T77993 arg1Of subunit,the
R73916 T25577 T56819 arg1Of protein,S
R73965 T68140 T88888 arg1Of affinities,of
R74139 T57345 T83927 arg1Of antibody,H2L2
R74668 T83470 T34654 arg2Of SARS-2-S,and
R74716 T48435 T19104 arg1Of protect,against
R74916 T17100 T66245 arg1Of mice,transgenic
R75181 T30814 T11300 arg2Of decreased,","
R7667 T25878 T32221 arg1Of mAb,A
R76879 T93532 T76093 arg2Of virus,of
R7737 T56920 T32531 arg1Of regions,immunoglobulin
R77514 T47874 T96386 arg1Of affinity,that
R77806 T40665 T56747 arg1Of antibodies,that
R78190 T47874 T77580 arg1Of affinity,for
R78219 T80909 T44111 arg2Of and,by
R78842 T98095 T78221 arg1Of chains,and
R79151 T56884 T11559 arg1Of binding,of
R79302 T57345 T48435 arg1Of antibody,protect
R79461 T72012 T55915 arg1Of supernatants,hybridoma
R80894 T58622 T53652 arg2Of contrast,By
R81151 T68894 T32288 arg2Of that,than
R81579 T25577 T24060 arg1Of protein,the
R82088 T18877 T18503 arg1Of receptor,[
R84017 T58127 T80909 arg2Of SARS2-S,and
R8404 T37245 T94688 arg1Of activity,such
R84051 T68140 T48175 arg1Of affinities,its
R84082 T68140 T71055 arg1Of affinities,","
R84230 T81589 T7888 arg2Of antibodies,compete
R85163 T73637 T99819 arg2Of S1B,i.e.
R85187 T39196 T24571 arg1Of and,both
R85301 T93924 T85248 arg1Of H2L2,might
R85602 T49873 T92338 arg1Of be,not
R8563 T68140 T91829 arg2Of affinities,in
R85824 T57345 T34464 arg1Of antibody,chimeric
R86711 T39196 T80967 arg2Of and,for
R8726 T98139 T85324 arg1Of repertoires,that
R87268 T56920 T19776 arg1Of regions,origin
R87567 T32517 T97000 arg2Of SARS-2-S.,of
R87983 T35671 T54239 arg2Of neutralize,can
R88560 T77445 T34654 arg1Of SARS-S,and
R8917 T40665 T35671 arg1Of antibodies,neutralize
R89642 T35671 T76245 arg1Of neutralize,[
R89938 T91104 T97128 arg2Of SARS-2-S,and
R90990 T98139 T24138 arg1Of repertoires,antibody
R91010 T18877 T48321 arg2Of receptor,to
R91021 T93924 T42126 arg1Of H2L2,47D11
R91166 T57345 T13041 arg1Of antibody,47D11
R91506 T78221 T55347 arg2Of and,express
R91773 T25878 T8625 arg1Of mAb,against
R92213 T9970 T32030 arg1Of domain,the
R92294 T56920 T28318 arg1Of regions,rat
R92430 T24633 T45480 arg1Of It,is
R92728 T38362 T39715 arg1Of interacting,with
R93366 T72012 T47163 arg1Of supernatants,containing
R9435 T36310 T28417 arg2Of infection,inhibit
R94533 T72563 T65069 arg1Of heavy,and
R94676 T98139 T66535 arg1Of repertoires,from
R95020 T24277 T1902 arg2Of S2,and
R95568 T18333 T86725 arg1Of cells,lung
R96321 T48435 T96346 arg2Of protect,and
R96452 T7869 T80909 arg1Of SARS-S,and
R96775 T89813 T95236 arg1Of SARS-S,could
R97129 T82065 T31100 arg1Of –,domain
R9737 T49120 T55070 arg1Of S1B,and
R98023 T18333 T60557 arg2Of cells,in
R98342 T56920 T16968 arg1Of regions,constant
R99048 T81589 T41843 arg1Of antibodies,neutralizing
R99609 T12942 T3419 arg2Of binding,block
R99987 T11815 T73902 arg1Of Rational,: